A variety of organizations are just starting to explore AI-based approaches to precision medicine. Deep Genomics, a Toronto startup, uses AI to reduce the amount of costly trial and error in drug discovery by analyzing large genomic databases, but its first clinical trial won’t be held until 2020.
How Machine Learning Is Crafting Precision Medicine
February 11, 2019

© 2025 DEEP GENOMICS. ALL RIGHTS RESERVED. PRIVACY POLICY